Deal Analysis March 3, 2026
The A$1.6bn Eucalyptus-HIMS Exit Deep Dive
A landmark analysis of the Eucalyptus Health sale to Hims & Hers — deal structure, earnouts, equity risk, and what it means for Australian venture.
M&Adeal analysisAustralia
Read more
→